Barclays PLC Maravai Lifesciences Holdings, Inc. Transaction History
Barclays PLC
- $854 Billion
- Q3 2025
A detailed history of Barclays PLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Barclays PLC holds 167,224 shares of MRVI stock, worth $608,695. This represents 0.0% of its overall portfolio holdings.
Number of Shares
167,224
Previous 214,885
22.18%
Holding current value
$608,695
Previous $517,000
7.35%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding MRVI
# of Institutions
182Shares Held
132MCall Options Held
688KPut Options Held
11.6K-
Gtcr LLC20.2MShares$73.3 Million6.38% of portfolio
-
12 West Capital Management LP New York, NY12.5MShares$45.6 Million4.42% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$35.4 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.35MShares$30.4 Million1.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.13MShares$25.9 Million0.0% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $479M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...